Humayun Mian Bilal, Khalid Sarah, Khalid Hamza, Zahoor Warda, Malik Waseem T
Internal Medicine, Shifa International Hospital, Islamabad, PAK.
Neurology, Shifa International Hospital, Islamabad, PAK.
Cureus. 2023 Feb 23;15(2):e35363. doi: 10.7759/cureus.35363. eCollection 2023 Feb.
We describe a case of encephalitis following coronavirus disease 2019 (COVID-19) in a six-and-a-half-year-old girl who presented with acute onset confusion and jerky movements of the limbs. The patient was unvaccinated for COVID-19. Subsequent magnetic resonance imaging revealed a bilateral "claustrum sign" on T2 and fluid-attenuated inversion recovery (FLAIR) images and electroencephalogram reported moderate diffuse encephalopathy. The patient tested negative for COVID-19 by polymerase chain reaction, had positive serology for COVID-19 indicating past infection, and had a negative autoimmune panel and infectious workup. She was treated on the lines of post-infectious encephalitis with immunomodulatory therapies such as high-dose intravenous steroids and intravenous immunoglobulins. She responded significantly and had complete resolution of her symptoms; therefore, further supporting the suspicion of an immune-mediated etiology. Cases of post-COVID-19 encephalitis have been reported all over the world; however, most cases are based on speculation and temporal associations and therefore more research is required to optimize treatment guidelines.
我们描述了一例2019冠状病毒病(COVID-19)后发生脑炎的6岁半女孩,她出现急性起病的意识模糊和肢体抽搐。该患者未接种COVID-19疫苗。随后的磁共振成像在T2加权像和液体衰减反转恢复(FLAIR)像上显示双侧“屏状核征”,脑电图报告为中度弥漫性脑病。该患者通过聚合酶链反应检测COVID-19呈阴性,COVID-19血清学呈阳性表明既往感染,自身免疫指标和感染相关检查均为阴性。她接受了针对感染后脑炎的治疗,采用了免疫调节疗法,如大剂量静脉注射类固醇和静脉注射免疫球蛋白。她反应显著,症状完全缓解;因此,进一步支持了免疫介导病因的怀疑。世界各地均有COVID-19后脑炎病例的报道;然而,大多数病例基于推测和时间关联,因此需要更多研究来优化治疗指南。